FULCRUM THERAPEUTICS

Fulcrum Therapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Thursday, August 3, 2023, at 8:00 a.m. ET

27 июл 2023 06:00:01 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology

10 июл 2023 06:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 июл 2023 16:30:31 Источник Nasdaq GlobeNewswire

Advocacy and Industry Partners Launch New Global Coalition to Speed Delivery of New Therapies for Facioscapulohumeral Muscular Dystrophy (FSHD)

20 июн 2023 06:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 июн 2023 15:54:20 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023

15 май 2023 06:05:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer

15 май 2023 06:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Monday, May 15, 2023, at 8:00 a.m. ET

08 май 2023 15:05:01 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 май 2023 17:06:50 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 апр 2023 16:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces CFO Resignation

05 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 мар 2023 16:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

09 мар 2023 06:00:01 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Thursday, March 9, 2023, at 8:00 a.m. ET

06 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease

24 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 фев 2023 16:27:22 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference

08 фев 2023 16:00:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

17 янв 2023 22:15:16 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock

17 янв 2023 15:01:00 Источник Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 янв 2023 16:00:00 Источник Nasdaq GlobeNewswire